Michael Liebowitz
Known title: DirectorCIK: 0001766109
Michael Liebowitz's purchase track record
How the stock did after each of Michael Liebowitz's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
8
of 8 since December 31, 2021
Stock higher 6 months later
38%
3 months: 38%
Median 6-month return
-18.0%
3 months: -12.7%
Beat the S&P 500
25%
median -17.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/18/2024 | DOUG | $1.82M | +6.1% | +13.2% | +1.2% |
| 7/10/2024 | DOUG | $233K | +27.6% | +28.5% | +5.1% |
| 8/18/2023 | DOUG | $21K | -18.6% | +0.5% | +14.5% |
| 10/7/2022 | DOUG | $392K | +10.0% | -21.1% | +12.9% |
| 6/29/2022 | DOUG | $2K | -9.2% | -14.9% | -0.9% |
| 3/30/2022 | DOUG | $2K | -34.6% | -40.6% | -19.2% |
| 3/4/2022 | DOUG | $203K | -16.2% | -30.9% | -9.3% |
| 12/31/2021 | DOUG | $57K | -35.5% | -53.8% | -19.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| DOUG | ▲ Buy | Grant | 1,250,000 | $0 | 4/10/2026 | View on chart |
| DOUG | ▼ Sell | Tax Withholding | 196,750 | $474K | 11/24/2025 | View on chart |
| DOUG | ▲ Buy | Grant | 1,500,000 | $0 | 11/24/2024 | View on chart |
| DOUG | ▲ Buy | Open Market | 1,081,414 | $1.8M | 11/18/2024 | View on chart |
| DOUG | ▲ Buy | Open Market | 197,398 | $233K | 7/10/2024 | View on chart |
| DOUG | ▲ Buy | Grant | 81,560 | $0 | 5/6/2024 | View on chart |
| DOUG | ▲ Buy | Open Market | 9,954 | $21K | 8/18/2023 | View on chart |
| DOUG | ▲ Buy | Grant | 30,000 | $0 | 3/14/2023 | View on chart |
| DOUG | ▲ Buy | Open Market | 40,000 | $157K | 10/10/2022 | View on chart |
| DOUG | ▲ Buy | Open Market | 60,000 | $235K | 10/7/2022 | View on chart |
| DOUG | ▲ Buy | Open Market | 345 | $2K | 6/29/2022 | View on chart |
| DOUG | ▲ Buy | Open Market | 242 | $2K | 3/30/2022 | View on chart |
| DOUG | ▲ Buy | Open Market | 15,000 | $100K | 3/7/2022 | View on chart |
| DOUG | ▲ Buy | Open Market | 15,000 | $102K | 3/4/2022 | View on chart |
| DOUG | ▲ Buy | Grant | 30,000 | $0 | 12/31/2021 | View on chart |
| DOUG | ▲ Buy | Open Market | 5,000 | $57K | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Citizens Begins Coverage of Douglas Elliman with Market Perform Rating
Citizens has started a research report on Douglas Elliman and assigned a Market Perform rating. The rating suggests a neutral outlook for the stock. The coverage may increase analyst attention and provide new information for investors. The stock is currently trading near its 52‑week low and shows a moderate RSI, indicating room for movement.
Citizens Begins Coverage of Douglas Elliman with Market Perform Rating. Citizens has started a research report on Douglas Elliman and assigned a Market Perform rating. The rating suggests a neutral outlook for the stock. The coverage may increase analyst attention and provide new information for investors. The stock is currently trading near its 52‑week low and shows a moderate RSI, indicating room for movement.